Brief: Crispr Therapeutics Highlights Strategic Priorities And Anticipated 2025 Milestones

Crispr Therapeutics AG

13/01/2025 13:42

Jan 13 (Reuters) - CRISPR Therapeutics AG  CRSP.BN :
    * CRISPR THERAPEUTICS HIGHLIGHTS STRATEGIC PRIORITIES AND
ANTICIPATED 2025 MILESTONES
    * TO ENGAGE REGULATORS ON CTX112 PATH FORWARD, UPDATE
MID-2025
    * DOSE ESCALATION FOR CTX310 AND CTX320 ONGOING, UPDATES
EXPECTED
H1 2025
    * ONGOING LAUNCH OF CASGEVY DRIVEN BY STRONG PATIENT DEMAND

Source text:  ID:nGNX4FZd3k 
Further company coverage:  CRSP.BN 

 ((Reuters.Briefs@thomsonreuters.com;))